NEW YORK (GenomeWeb) – UK-based Genedrive announced today that it has signed a conditional agreement with a firm called Epistem 2 to sell its contract research and pharmacogenomics divisions for a cash consideration of up to £1.9 million ($2.6 million), as part of a strategy to focus entirely on the molecular diagnostics market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.